Vicarius Leadership Team – Executive Profiles

Chief Medical/Scientific Officer

Professional Experience

Owner and founder, TriMED Healthcare Consulting, Switzerland

Vice President, Clinical Development, Biogen, Switzerland

Vice President, Late Stage Development, Biogen, Switzerland

Vice President, Translational Medicine, Biogen, Switzerland

Chief Medical Officer, Eidetica (Biogen spin-off), Switzerland

Global Clinical Director and European Medical Director, Psychiatry, Janssen Cilag EMEA

European Brand Leader, Neuroscience Medical Director, Bristol-Myers Squibb Germany

Clinical Research Physician, CNS, Eli Lilly, Germany

Consultant, Preclinical and Clinical Research, Fidia Research Laboratory, Italy

Assistant Professor of Neurology, Columbia University Medical Center, Presbyterian Hospital, New York

 

Key Achievements

Biogen

  • Biosimilars (indications: RA, oncology) European launch preparation, including KOL engagement and sales force training
  • European Tecfidera registration including European regulatory authorities negotiations for data protection
  • Plan, develop and implement a European expert engagement network of academia, policy makers, key scientific and medical experts and influencers to support pre- and post-launch activities
  • Key activities for EMEA approval of Fampyra and Tecfidera
  • Fampridine-PR: MAA dossier and submission of this in-licensed drug achieved within one month, negotiated and obtained waiver of the pediatric clinical dossier, normally mandatory to allow EU registration
  • Win of Fampyra appeal: from negative (1 positive and 29 negative votes) CHMP opinion to a positive opinion and approval, achieved within 3 months time
  • Medical support for market access: health economic dossier for European countries, including the AMNOG process in Germany

 

Janssen-Cilag

  • As Global leader for Concerta (ADHD), tailored European development of an indication previously not recognized in Europe (adult ADHD)
  • Medical Affairs: successful EU lifecycle activities for blockbuster brands (e.g Rispedal, Risperdal Consta, Concerta) with top ROI

 

Bristol-Myers Squibb

  • EU launch and successful label extension of Abilify

 

Education

M.D., Residency Neurology, Bologna University, School of Medicine, Italy

USA: ECFMG license n. 395-840-2

USA medical licensing: Federation Licensing Examination (FLEX) New York State

Post-doctoral fellowships: Case Western Reserve University and Washington University.

 

Nationality

Italian

Languages

Italian, English, German

 

Other Executive Team

Member Profiles

  • President and CEO
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Pre-Approval Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Post-Approval Regulatory Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Compliance Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Vice President, Market Access
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Head of Business Development,
  • Legal & External Affairs
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Chief Financial Officer
  • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • Vice President,
  • Head of Commercial Strategy